SCHEMBL9378626

SCHEMBL9378626

CCCCOc1ccc(N2N=C(Cc3ncc[nH]3)CC2=O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SHMT2 P34897 1/20 0.45
▸ CYP19A1 P11511 5/20 0.44
▸ CYP1A2 P05177 5/20 0.44
▸ CYP2D6 P10635 5/20 0.44
▸ CYP2C9 P11712 5/20 0.44
▸ CYP2C19 P33261 5/20 0.44
▸ CYP3A4 P08684 4/20 0.44
▸ GAA P10253 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ PABPC1 P11940 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ HTR1A P08908 1/20 0.37
▸ TAAR1 Q96RJ0 1/20 0.37
▸ APP P05067 1/20 0.37
▸ LMNA P02545 2/20 0.36
▸ PLA2G2A P14555 2/20 0.36
▸ NPY1R P25929 1/20 0.36
▸ NPY2R P49146 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9385358 0.91 GAA (0.45) SHMT2CYP2D6CYP2C9GAAMEN1
SCHEMBL9378519 0.87 GAA (0.57) SHMT2GAAMEN1KMT2AALDH1A1
SCHEMBL9380406 0.87 SHMT2 (0.45) SHMT2GAAMEN1KMT2AALDH1A1
SCHEMBL9378209 0.85 SHMT2 (0.46) SHMT2CYP1A2CYP3A4GAAMEN1
SCHEMBL9379615 0.84 SHMT2 (0.49) SHMT2CYP1A2CYP3A4GAAMEN1
SCHEMBL9379481 0.82 SHMT2 (0.56) SHMT2CYP1A2CYP3A4GAAMEN1
SCHEMBL9379697 0.81 SHMT2 (0.42) SHMT2GAAMEN1KMT2AALDH1A1
SCHEMBL9379889 0.81 KMT2A (0.49) SHMT2GAAMEN1KMT2AALDH1A1
SCHEMBL9378235 0.81 SHMT2 (0.42) SHMT2CYP1A2CYP3A4GAAMEN1
SCHEMBL9382005 0.80 MAPT (0.48) SHMT2GAAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0269030-B1 Lipid-peroxide formation inhibiting composition and novel compounds useful therefor MITSUBISHI CHEM IND (JP) 1994-05-04 — — EP disclosed
US-5089515-A Antiischemic agents; pyrazolone compounds MITSUBISHI KASEI CORPORATION (JP) 1992-02-18 — — US disclosed
US-4990619-A Cardiovascular disorders, antiischemic agents MITSUBISHI KASEI CORPORATION (JP) 1991-02-05 — — US disclosed
US-4906644-A Lipid-peroxide formation inhibiting composition and novel compounds useful therefor MITSUBISHI KASEI CORPORATION (JP) 1990-03-06 — — US disclosed
EP-0269030-A2 Lipid-peroxide formation inhibiting composition and novel compounds useful therefor MITSUBISHI KASEI CORPORATION (JP) 1988-06-01 — — EP disclosed
Send feedback